000 | 01475 a2200385 4500 | ||
---|---|---|---|
005 | 20250514211732.0 | ||
264 | 0 | _c20041221 | |
008 | 200412s 0 0 eng d | ||
022 | _a0007-1285 | ||
024 | 7 |
_a10.1259/bjr/27373639 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSeddon, B M | |
245 | 0 | 0 |
_aThe role of functional and molecular imaging in cancer drug discovery and development. _h[electronic resource] |
260 |
_bThe British journal of radiology _c2003 |
||
300 |
_aS128-38 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacokinetics |
650 | 0 | 4 | _aBenzoquinones |
650 | 0 | 4 |
_aDiagnostic Imaging _xmethods |
650 | 0 | 4 |
_aHSP90 Heat-Shock Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoxia _xphysiopathology |
650 | 0 | 4 | _aLactams, Macrocyclic |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 | _aNitroimidazoles |
650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
650 | 0 | 4 |
_aRifabutin _xanalogs & derivatives |
650 | 0 | 4 |
_aTechnology, Pharmaceutical _xmethods |
650 | 0 | 4 |
_aUltrasonography _xmethods |
700 | 1 | _aWorkman, P | |
773 | 0 |
_tThe British journal of radiology _gvol. 76 Spec No 2 _gp. S128-38 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1259/bjr/27373639 _zAvailable from publisher's website |
999 |
_c15257680 _d15257680 |